Corticosteroid resistance in chronic obstructive pulmonary disease: Inactivation of histone deacetylase

Lancet

Volumn 363, Issue 9410, 2004, Pages 731-733

  Barnes, Peter J ^a   Ito, Kazuhiro ^a   Adcock, Ian M ^a  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; HISTONE DEACETYLASE; PEROXYNITRITE;

ACETYLATION; ARTICLE; ASTHMA; CHROMATIN STRUCTURE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CIGARETTE SMOKING; DRUG EFFECT; ENZYME ACTIVATION; GENE ACTIVATION; GENE FUNCTION; GENETIC TRANSCRIPTION; HUMAN; NITRATION; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN SYNTHESIS;

EID: 1542301591     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(04)15650-X     Document Type: Note

References (28)

1. Barnes P.J. Inhaled corticosteroids are not helpful in chronic obstructive pulmonary disease. Am J Resp Crit Care Med. 161:2000;342-344.
2. Alsaeedi A., Sin D.D., McAlister F.A. The effects of inhaled corticosteroids in chronic obstructive pulmonary disease: a systematic review of randomized placebo-controlled trials. Am J Med. 113:2002;59-65.
3. Keatings V.M., Jatakanon A., Worsdell Y.M., Barnes P.J. Effects of inhaled and oral glucocorticoids on inflammatory indices in asthma and COPD. Am J Respir Crit Care Med. 155:1997;542-548.
4. Culpitt S.V., Nightingale J.A., Barnes P.J. Effect of high dose inhaled steroid on cells, cytokines and proteases in induced sputum in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 160:1999;1635-1639.
5. Hattotuwa K.L., Gizycki M.J., Ansari T.W., Jeffery P.K., Barnes N.C. The effects of inhaled fluticasone on airway inflammation in chronic obstructive pulmonary disease: a double-blind, placebo-controlled biopsy study. Am J Respir Crit Care Med. 165:2002;1592-1596.
6. Russell R.E., Culpitt S.V., DeMatos C., et al. Release and activity of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 by alveolar macrophages from patients with chronic obstructive pulmonary disease. Am J Respir Cell Mol Biol. 26:2002;602-609.
7. Culpitt S.V., Rogers D.F., Shah P., et al. Impaired inhibition by dexamethasone of cytokine release by alveolar macrophages from patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 167:2003;24-31.
8. Leung D.Y., Bloom J.W. Update on glucocorticoid action and resistance. J Allergy Clin. Immunol. 111:2003;3-22.
9. Barnes P.J., Adcock I.M. How corticosteroid switch off inflammation in asthma. Ann Intern Med. 139:2003;359-370.
10. Ito K., Barnes P.J., Adcock I.M. Glucocorticoid receptor recruitment of histone deacetylase 2 inhibits IL-1b-induced histone H4 acetylation on lysines 8 and 12. Mol Cell Biol. 20:2000;6891-6903.
11. Ito K., Caramori G., Lim S., et al. Expression and activity of histone deacetylases (HDACs) in human asthmatic airways. Am J Respir Crit Care Med. 166:2002;392-396.
12. Ito K., Lim S., Caramori G., Chung K.F., Barnes P.J., Adcock I.M. Cigarette smoking reduces histone deacetylase 2 expression, enhances cytokine expression and inhibits glucocorticoid actions in alveolar macrophages. FASEB J. 15:2001;1100-1102.
13. Ito K., Watanabe S., Kharitonov S., Hanazawa T., Adcock I.M., Barnes P.J. Histone deacetylase activity and gene expression in COPD patients. Eur Resp J. 18 (suppl):2001;316.
14. Montuschi P., Collins J.V., Ciabattoni G., et al. Exhaled 8-isoprostane as an in vivo biomarker of lung oxidative stress in patients with COPD and healthy smokers. Am J Respir Crit Care Med. 162:2000;1175-1177.
15. Paredi P., Kharitonov S.A., Leak D., Ward S., Cramer D., Barnes P.J. Exhaled ethane, a marker of lipid peroxidation, is elevated in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 162:2000;369-373.
16. Tomita K., Barnes P.J., Adcock I.M. The effect of oxidative stress on histone acetylation and IL-8 release. Biochem Biophys Res Comm. 301:2003;572-577.
17. Rahman I. Oxidative stress, chromatin remodeling and gene transcription in inflammation and chronic lung diseases. J Biochem Mol Biol. 36:2003;95-109.
18. Di Stefano A., Caramori G., Capelli A., et al. Increased expression of NF-κB in bronchial bioipsies from smokers and patients with COPD. Eur Resp J. 20:2002;556-563.
19. Ichinose M., Sugiura H., Yamagata S., Koarai A., Shirato K. Increase in reactive nitrogen species production in chronic obstructive pulmonary disease airways. Am J Respir Crit Care Med. 160:2000;701-706.
20. Montuschi P., Ciabattoni G., Corradi M., et al. Increased 8-isoprostane, a marker of oxidative stress, in exhaled condensates of asthmatic patients. Am J Respir Crit Care Med. 160:1999;216-220.
21. Chalmers G.W., Macleod K.J., Little S.A., Thomson L.J., McSharry C.P., Thomson N.C. Influence of cigarette smoking on inhaled corticosteroid treatment in mild asthma. Thorax. 57:2002;226-230.
22. Hansel T.T., Kharitonov S.A., Donnelly L.E., et al. A selective inhibitor of inducible nitric oxide synthase inhibits exhaled breath nitric oxide. FASEB J. 17:2003;1298-1300.
23. Ito K., Lim S., Caramori G., Cosio B., et al. A molecular mechanism of action of theophylline: Induction of histone deacetylase activity to decrease inflammatory gene expression. Proc Natl Acad Sci USA. 99:2002;8921-8926.
24. Ito K., Lim S., Chung K.F., Barnes P.J., Adcock I.M. Theophylline enhances histone deacetylase activity and restores glucocorticoid function during oxidative stress. Am J Respir Crit Care Med. 165:2002;625.
25. Culpitt S.V., de Matos C., Russell R.E., Donnelly L.E., Rogers D.F., Barnes P.J. Effect of theophylline on induced sputum inflammatory indices and neutrophil chemotaxis in COPD. Am J Respir Crit Care Med. 165:2002;1371-1376.
26. Barnes P.J. Theophylline: new perspectives on an old drug. Am J Respir Crit Care Med. 167:2003;813-818.
27. Szafranski W., Cukier A., Ramirez A., et al. Efficacy and safety of budesonide/formoterol in the management of chronic obstructive pulmonary disease. Eur Respir J. 21:2003;74-81.
28. Calverley P., Pauwels R., Vestbo J., et al. Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease: a randomised controlled trial. Lancet. 361:2003;449-456.